FLAVIN JOHN L has filed 4 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 45867 shares of Pyxis Oncology, Inc. ($PYXS) on March 24, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 24, 2026 | Pyxis Oncology, Inc. | $PYXS | FLAVIN JOHN L | Not found | A | Stock Option (Right to Buy) | 45867 | $0.00 | 45,867.0000 | 62,557,386 | 9999.99% | 0.07% |
| March 31, 2025 | Pyxis Oncology, Inc. | $PYXS | FLAVIN JOHN L | Not found | A | Stock Option (Right to Buy) | 36979 | $0.98 | 36,979.0000 | 58,445,765 | 9999.99% | 0.06% |
| March 26, 2024 | Pyxis Oncology, Inc. | $PYXS | FLAVIN JOHN L | Not found | A | Common Stock | 35219 | $0.00 | 413,015.0000 | 39,904,603 | 9.32% | 0.09% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | FLAVIN JOHN L | Director | A | Common Stock | 139355 | $0.00 | 377,796.0000 | 0 | 58.44% | 0.00% |